Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

<p>Abstract</p> <p>Background</p> <p>Conventional magnetic resonance imaging (MRI) has improved the diagnosis and monitoring of multiple sclerosis (MS). In clinical trials, MRI has been found to detect treatment effects with greater sensitivity than clinical measures; h...

Full description

Bibliographic Details
Main Authors: Quarantelli Mario, Galletti Stefano, Luccichenti Giacomo, Trojano Maria, Tola Maria-Rosalia, Amato Maria, Giugni Elisabetta, Bastianello Stefano, Picconi Orietta, Patti Francesco
Format: Article
Language:English
Published: BMC 2011-10-01
Series:BMC Neurology
Online Access:http://www.biomedcentral.com/1471-2377/11/125

Internet

http://www.biomedcentral.com/1471-2377/11/125

Similar Items